From be8f4ffaa545ac2830721ab21215e51331776023 Mon Sep 17 00:00:00 2001
From: Christina Conrad <114612268+cconrad8@users.noreply.github.com>
Date: Wed, 16 Aug 2023 10:26:02 -0400
Subject: [PATCH 1/2] Delete awardees.mdx

---
 pages/awardees.mdx | 47 ----------------------------------------------
 1 file changed, 47 deletions(-)
 delete mode 100644 pages/awardees.mdx

diff --git a/pages/awardees.mdx b/pages/awardees.mdx
deleted file mode 100644
index 4d9d723..0000000
--- a/pages/awardees.mdx
+++ /dev/null
@@ -1,47 +0,0 @@
-**Devising new strategies to track and prevent breast cancer development in BRCA mutation carriers**  
-**Joan Brugge** | _Harvard Ludwig Cancer Center and Harvard Medical School_
-* How do basal and luminal breast cells contribute to BRCA-related cancers?
-* How do BRCA tumor cells evolve?
-* What are the molecular defects during tumor evolution?
-* How do we detection cancer evolution in carriers?
-* How do we intercept and eradicate tumor development?
-
----
-
-**Dissecting early pathogenesis of BRCA1/2-associated cancer for risk prediction and prevention**  
-**Leif Ellisen** | _Harvard Medical School, Massachusetts General Hospital Cancer Center_
-* What are the early changes in cells of BRCA carrier breast tissue?
-* What are the BRCA cellular vulnerabilities?
-* What are tissue-based markers for prevention approaches?
-
----
-
-**Interplay and perturbations of the local microbiome and host immune system in breast cancer**  
-**Charis Eng** | _Cleveland Clinic_
-* What are the differences in microbes found with normal versus BRCA breast cancers?
-* How do microbes contribute to immune changes 
-and cancer?
-* Could microbiome engineering prevent cancer?
-
----
-
-**Determinants of immune activity and molecular features in BRCA1/2 mutation carriers**  
-**Katherine Nathanson** | _University of Pennsylvania_
-* What are the immune functional status in BRCA carriers?
-* Are there associations between molecular and immune status with therapeutic response and survival?
-
----
-
-**Dissection of BRCA-mediated Tumor Suppression Pathways**  
-**Patrick Sung** | _Univ. of Texas Health Science Center at San Antonio_
-* What are the regulators of BRCA function?
-* What are BRCA-independent DNA repair pathways?
-* What are the DNA repair mechanisms?
-* What are the drug vulnerabilities of BRCA deficient cells?
-
----
-
-**Early detection of cancer in high-risk BRCA mutation carriers using liquid biopsies**  
-**Victor Velculescu** | _Johns Hopkins University_
-* What are the molecular characteristics of circulation free DNA in BRCA carriers with and without cancer?
-* What is the strategy for screening?

From ba096b94275115d4d78f4f38aca5956e70648cd0 Mon Sep 17 00:00:00 2001
From: Christina Conrad <114612268+cconrad8@users.noreply.github.com>
Date: Wed, 16 Aug 2023 10:26:15 -0400
Subject: [PATCH 2/2] Update _meta.json

---
 pages/_meta.json | 3 +--
 1 file changed, 1 insertion(+), 2 deletions(-)

diff --git a/pages/_meta.json b/pages/_meta.json
index 22c8ed5..3313374 100644
--- a/pages/_meta.json
+++ b/pages/_meta.json
@@ -1,9 +1,8 @@
 {
   "index": "Home",
   "governance": "Governance",
-  "awardees": "Awardees",
   "onboarding": "Onboarding",
   "data-model": "Data Model",
   "data-portal": "Data Portal",
   "faq": "Frequently Asked Questions"
-}
\ No newline at end of file
+}